Loading clinical trials...
Loading clinical trials...
A Study of Korean Red Ginseng for Evaluation of Improvement of Cancer-related Fatigue in Patients With Colorectal Cancer With Chemotherapy: A Randomized, Double-blind, Placebo-Controlled, Parallel, Multicenter Trial
Conditions
Interventions
Korean Red Ginseng
Placebo
Locations
1
South Korea
Korea Ginseng Corporation
Shinseongdong, Daejeon, South Korea
Start Date
December 1, 2013
Primary Completion Date
August 1, 2016
Completion Date
March 1, 2017
Last Updated
August 11, 2017
NCT04704661
NCT06696768
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
Korea Ginseng Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions